Literature DB >> 3177069

Risk factors for late relapse in male and female ex-smokers.

G E Swan1, C E Denk, S D Parker, D Carmelli, C T Furze, R H Rosenman.   

Abstract

Three hundred twenty-nine ex-smokers (149 males and 180 females) who had maintained abstinence for at least 3 months prior to intake were followed for a period of 1 year to ascertain individual characteristics from cognitive, behavioral, environmental, and health domains that were predictive of later relapse. Multiple logistic regression analysis revealed significant associations between relapse, family history, and stress variables in males and between relapse, family history, stress, pre- and postcessation smoking characteristics, work-related variables, and physical activity in females. Within the predictor sets, both risk and protective factors were identified. The male and female models are discussed separately, compared, and related to previous research. Implications for further model development are specified; most notably, the utility of conceptualizing relapse independent of gender is questioned. Future research efforts could focus on the role played by family smoking history in adult relapse behavior. Smoking cessation interventions may need to tailor their efforts specifically to men and to women. Along with techniques to manage stress both during and after cessation, women may benefit especially from interventions that provide nicotine replacement and counseling for work-related difficulties.

Entities:  

Mesh:

Year:  1988        PMID: 3177069     DOI: 10.1016/0306-4603(88)90052-4

Source DB:  PubMed          Journal:  Addict Behav        ISSN: 0306-4603            Impact factor:   3.913


  24 in total

1.  Predictors of continued smoking over 25 years of follow-up in the normative aging study.

Authors:  B L Nordstrom; T Kinnunen; C H Utman; E A Krall; P S Vokonas; A J Garvey
Journal:  Am J Public Health       Date:  2000-03       Impact factor: 9.308

Review 2.  Craving to quit: psychological models and neurobiological mechanisms of mindfulness training as treatment for addictions.

Authors:  Judson A Brewer; Hani M Elwafi; Jake H Davis
Journal:  Psychol Addict Behav       Date:  2012-05-28

3.  Stress and quitting among African American smokers.

Authors:  Brian K Manning; Delwyn Catley; Kari Jo Harris; Matthew S Mayo; Jasjit S Ahluwalia
Journal:  J Behav Med       Date:  2005-08

Review 4.  Theory-based processes that promote the remission of substance use disorders.

Authors:  Rudolf H Moos
Journal:  Clin Psychol Rev       Date:  2006-12-30

5.  The development and structural confirmation of the Rhode Island Stress and Coping Inventory.

Authors:  J L Fava; L Ruggiero; D M Grimley
Journal:  J Behav Med       Date:  1998-12

Review 6.  Biological mechanisms underlying the relationship between stress and smoking: state of the science and directions for future work.

Authors:  Jessica M Richards; Brooke A Stipelman; Marina A Bornovalova; Stacey B Daughters; Rajita Sinha; C W Lejuez
Journal:  Biol Psychol       Date:  2011-07-07       Impact factor: 3.251

7.  Effects of Disasters on Smoking and Relapse: An Exploratory Study of Hurricane Katrina Victims.

Authors:  Jennifer Q Lanctot; Michelle B Stockton; Fawaz Mzayek; Mary Read; Meghan McDevitt-Murphy; Kenneth Ward
Journal:  Am J Health Educ       Date:  2013-01-23

8.  Neural stress reactivity relates to smoking outcomes and differentiates between mindfulness and cognitive-behavioral treatments.

Authors:  Hedy Kober; Judson A Brewer; Keri L Height; Rajita Sinha
Journal:  Neuroimage       Date:  2016-09-28       Impact factor: 6.556

9.  Corticotropin-releasing factor-1 receptor activation mediates nicotine withdrawal-induced deficit in brain reward function and stress-induced relapse.

Authors:  Adrie W Bruijnzeel; Melissa Prado; Shani Isaac
Journal:  Biol Psychiatry       Date:  2009-02-12       Impact factor: 13.382

10.  Smoking, social support, and hassles in an urban African-American community.

Authors:  P S Romano; J Bloom; S L Syme
Journal:  Am J Public Health       Date:  1991-11       Impact factor: 9.308

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.